company background image
NR1A logo

National Research BST:NR1A Stock Report

Last Price

€16.60

Market Cap

€371.2m

7D

0%

1Y

n/a

Updated

01 Feb, 2025

Data

Company Financials

National Research Corporation

BST:NR1A Stock Report

Market Cap: €371.2m

NR1A Stock Overview

Provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. More details

NR1A fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance1/6
Financial Health2/6
Dividends3/6

Rewards

Trading at 57.4% below our estimate of its fair value

Risk Analysis

Shares are highly illiquid

Earnings have declined by 6.1% per year over past 5 years

Has a high level of debt

Unstable dividend track record


My Notes

Capture your thoughts, links and company narrative

National Research Corporation Competitors

SYNLAB

HMSE:SYAB

€2.5b

VITA 34

XTRA:V3V

€70.8m

Fresenius Medical Care

XTRA:FME

€14.1b

M1 Kliniken

XTRA:M12

€274.6m

Price History & Performance

Summary of share price highs, lows and changes for National Research
Historical stock prices
Current Share PriceUS$16.60
52 Week HighUS$18.20
52 Week LowUS$16.50
Beta0.55
1 Month Change-8.29%
3 Month Changen/a
1 Year Changen/a
3 Year Change-51.18%
5 Year Change-73.23%
Change since IPO-33.96%

Recent News & Updates

Recent updates

Shareholder Returns

NR1ADE HealthcareDE Market
7D0%1.5%1.9%
1Yn/a39.2%15.1%

Return vs Industry: Insufficient data to determine how NR1A performed against the German Healthcare industry.

Return vs Market: Insufficient data to determine how NR1A performed against the German Market.

Price Volatility

Is NR1A's price volatile compared to industry and market?
NR1A volatility
NR1A Average Weekly Movementn/a
Healthcare Industry Average Movement4.8%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: NR1A's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine NR1A's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1981435Mike Hayswww.nrchealth.com

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools.

National Research Corporation Fundamentals Summary

How do National Research's earnings and revenue compare to its market cap?
NR1A fundamental statistics
Market cap€371.21m
Earnings (TTM)€23.91m
Revenue (TTM)€138.01m

15.5x

P/E Ratio

2.7x

P/S Ratio

Is NR1A overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NR1A income statement (TTM)
RevenueUS$143.06m
Cost of RevenueUS$56.93m
Gross ProfitUS$86.13m
Other ExpensesUS$61.34m
EarningsUS$24.78m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.07
Gross Margin60.20%
Net Profit Margin17.32%
Debt/Equity Ratio200.4%

How did NR1A perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

46%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 09:21
End of Day Share Price 2025/01/07 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

National Research Corporation is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Frank SparacinoFirst Analysis Securities Corporation
Ryan DanielsWilliam Blair & Company L.L.C.